Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19
The Impact of Education on the Rehabilitation of Patients Hospitalized Due to Pneumonia With Confirmed COVID-19
1 other identifier
interventional
100
1 country
1
Brief Summary
The planned research will enable the assessment of rehabilitation's effects using two pulmonary rehabilitation models: conventional and supplemented with an education program for patients hospitalized due to pneumonia with confirmed COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2024
CompletedFirst Posted
Study publicly available on registry
July 26, 2024
CompletedStudy Start
First participant enrolled
July 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2024
CompletedNovember 6, 2024
November 1, 2024
2 months
July 19, 2024
November 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Vital capacity (Voldyne 5000)
Measurements will be performed with certified motivational spirometer, Voldyne 5000. Patient, in a sitting position, will inhale as much air as possible starting from residual volume (RV) level and approach to vital capacity (VC) level. The result will be read from the scale placed on the wall of the device.
First examination- before the start of the 14-day rehabilitation program
Vital capacity (Voldyne 5000)
Measurements will be performed with certified motivational spirometer, Voldyne 5000. Patient, in a sitting position, will inhale as much air as possible starting from residual volume (RV) level and approach to vital capacity (VC) level. The result will be read from the scale placed on the wall of the device.
Second examination- at the end of the 14-day rehabilitation program
Oxygen saturation
Measurements will be performed with pulse oximeter and the parameter analyzed will be SpO2 (oxygen saturation by pulse oximetry; percentage of oxygen in patients' blood).
First examination- before the start of the 14-day rehabilitation program
Oxygen saturation
Measurements will be performed with pulse oximeter and the parameter analyzed will be SpO2 (oxygen saturation by pulse oximetry; percentage of oxygen in patients' blood).
Second examination- at the end of the 14-day rehabilitation program
Acid-base balance
The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2).
First examination- before the start of the 14-day rehabilitation program
Acid-base balance
The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2).
Second examination- at the end of the 14-day rehabilitation program
Secondary Outcomes (10)
Physical performance assessment by Sit-to-Stand Test (STS)
First examination- before the start of the 14-day rehabilitation program
Physical performance assessment by Sit-to-Stand Test (STS)
Second examination- at the end of the 14-day rehabilitation program
Fatigue assessment using modified Borg scale
First examination- before the start of the 14-day rehabilitation program
Fatigue assessment using modified Borg scale
Second examination- at the end of the 14-day rehabilitation program
Dyspnea assessment with Medical Research Council dyspnea scale
First examination- before the start of the 14-day rehabilitation program
- +5 more secondary outcomes
Study Arms (2)
Education program and Pulmonary rehabilitation
EXPERIMENTALConventional pulmonary rehabilitation coupled with original education program.
Pulmonary rehabilitation
OTHERConventional pulmonary rehabilitation
Interventions
Patients in a study group will participate in daily education program using an original brochure containing information about self-management during the treatment process, the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise.
The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.
Eligibility Criteria
You may qualify if:
- Hospitalization due to pneumonia due to COVID-19
- Positive SARS-COV-2 PCR test
- Independence in in-bed sitting position with lower extremities placed on the floor
- Age 40 y.o. to 70 y.o.
- No additional respiratory support (e.a. cardiopulmonary bypass machine, ventilator)
- Informed, voluntary consent to participate in research.
You may not qualify if:
- Hospitalization due to pneumonia with negative SARS-COV-2 PCR test
- Unstable medical condition hindering performing the examination
- Age under 40 y.o. and over 70 y.o.
- Cognitive deficits impairing the ability to understand and execute commands
- Concomitant oncological, neurological, orthopedic, and psychiatric diseases may affect the examined persons' circulatory and respiratory functions, functional efficiency, quality of life, and emotional state.
- Failure to complete a 14-day rehabilitation program
- Lack of informed, voluntary consent to participate in research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rzeszów
Rzeszów, 35-959, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renata Borys, MSc
University of Rzeszow
- STUDY DIRECTOR
Agnieszka Guzik, A/Prof
University of Rzeszow
- STUDY CHAIR
Magdalena Kołodziej, PhD
University of Rzeszow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc
Study Record Dates
First Submitted
July 19, 2024
First Posted
July 26, 2024
Study Start
July 26, 2024
Primary Completion
September 26, 2024
Study Completion
October 26, 2024
Last Updated
November 6, 2024
Record last verified: 2024-11